Inventor · disambiguated record
Shalini Singh
Also filed as: SINGH SHALINI
8 granted patents·11 pending applications·11 citations·filing 2010–2023
79Inventor score
Files withVENTANA MED SYST INC14KLARIA PHARMA HOLDING AB2SINGH SHALINI2ROCHE DIAGNOSTICS OPERATIONS INC1
Top patents by PatentIndex Score
19 records- 0187US10852304B2Materials and methods for performing histochemical assays for human pro-epiregulin and amphiregulinVENTANA MED SYST INC·Filed 2017·Granted Dec 1, 2020·3 cites·19 claims
- 0286US9651555B2Method of identifying treatment responsive non-small cell lung cancer using anaplastic lymphoma kinase (ALK) as a markerVENTANA MED SYST INC·Filed 2013·Granted May 16, 2017·6 cites·3 claims
- 0382US12419201B2Materials and methods for performing histochemical assays for human pro-epiregulin and amphiregulinVENTANA MED SYST INC·Filed 2023·Granted Sep 23, 2025·0 cites·25 claims
- 0476US2023184772A1Method of identifying treatment responsive non-small cell lung cancer using anaplastic lymphoma kinase (alk) as a markerVENTANA MED SYST INC·Filed 2022·Application pending·0 cites
- 0571US11747339B2Materials and methods for performing histochemical assays for human pro-epiregulin and amphiregulinVENTANA MED SYST INC·Filed 2020·Granted Sep 5, 2023·0 cites·20 claims
- 0671US10755406B2Systems and methods for co-expression analysis in immunoscore computationVENTANA MED SYST INC·Filed 2017·Granted Aug 25, 2020·2 cites·37 claims
- 0770US2024041761A1Pharmaceutical FormulationKLARIA PHARMA HOLDING AB·Filed 2023·Application pending·0 cites
- 0868US11499974B2Method of identifying treatment responsive non-small cell lung cancer using anaplastic lymphoma kinase (ALK) as a markerVENTANA MED SYST INC·Filed 2020·Granted Nov 15, 2022·0 cites·11 claims
- 0963US2022051804A1Image Analysis for Breast Cancer PrognosisVENTANA MED SYST INC·Filed 2021·Application pending·0 cites
- 1062US10620207B2Method of identifying treatment responsive non-small cell lung cancer using anaplastic lymphoma kinase (ALK) as a markerVENTANA MED SYST INC·Filed 2017·Granted Apr 14, 2020·0 cites·11 claims
- 1159US2021346277A1Pharmaceutical FormulationKLARIA PHARMA HOLDING AB·Filed 2019·Application pending·0 cites
- 1258US2023280345A1Prediction of response to epidermal growth factor receptor-directed therapies using epiregulin and amphiregulinVENTANA MED SYST INC·Filed 2023·Application pending·0 cites
- 1355US2023340147A1Antibodies specific for alpha-1,6-core-fucosylated psa and fucosylated fragments thereofROCHE DIAGNOSTICS OPERATIONS INC·Filed 2023·Application pending·0 cites
- 1451US11211167B2Image analysis for breast cancer prognosisVENTANA MED SYST INC·Filed 2013·Granted Dec 28, 2021·0 cites·11 claims
- 1549US2016130666A1Simultaneous detection of mutational status and gene copy numberVENTANA MED SYST INC·Filed 2016·Application pending·0 cites
- 1644US2012264127A1Simultaneous detection of mutational status and gene copy numberSINGH SHALINI·Filed 2010·Application pending·0 cites
- 1740US2019269716A1Compositions and methods for prognosing and treating colorectal cancerVENTANA MED SYST INC·Filed 2019·Application pending·0 cites
- 1836US2012141472A1Methods of scoring gene copy number in a biological sample using in situ hybridizationSINGH SHALINI·Filed 2010·Application pending·0 cites
- 1931US2017038385A1G-Alpha Interacting Vesicle Associated Protein (GIV) as a Predictive Marker in Stage II Colorectal CancerVENTANA MED SYST INC·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Shalini Singh files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →